Erythrocyte adhesion to vascular endothelium: Clinical applications;Adhesion des hematies a l'endothelium vasculaire: Applications en pathologie

Revue de Medecine Interne

Volumn 21, Issue 7, 2000, Pages 599-607

  Chaudet, B ^a   Renard, M ^a   Seigneur, M ^a   Boisseau, M R ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Adhesion; Diabetes mellitus; Endothelium; Malaria; Red blood cells; Sickle cell disease

Indexed keywords

LIGAND; RECEPTOR;

ARTICLE; CELL HETEROGENEITY; CELL INTERACTION; CELL SUBPOPULATION; DIABETES MELLITUS; ENDOTHELIUM CELL; ENVIRONMENTAL FACTOR; ERYTHROCYTE ADHESIVENESS; MALARIA; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM; ANIMAL; BLOOD; CELL ADHESION; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANEMIA, SICKLE CELL; ANIMALS; CELL ADHESION; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HUMANS; MALARIA;

EID: 0034235676     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)80005-3     Document Type: Article

References (71)

1. 1 Mc Evoy L., Williamson P., Schlegel R.A.. Membrane phospholipid asymetry as a determinant of erythrocyte recognition by macrophages. Proc Natl Acad Sci USA 1986; 83: 3311-5.
2. 2 Brownlee M, Cerami A.. The biochemistry of the complications of diabetes mellitus. Annu Rev Biochem 1981; 50: 385-32.
3. 3 Wautier JL, Paton C, Wautier MP, Pintigny D, Abadie E, Passa P, et al. Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Engl J Med 1981; 305: 237-42.
4. 4 Wautier J, Pintigny D, Wautier M, Paton R, Galacteros F, Passa P, et al. Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium. J Lab Clin Med 1983; 101: 911-8.
5. 5 Wali R, Jaffe S, Kumar D, Sorgente N. Kalra V. Increased adherence of treated human and bovine erythrocytes to cultured endothelial cells. J Cell Physiol 1987; 133: 25-36.
6. 6 Rabini R, Fumelli P, Galassi R, Dousset N, Taus M, Ferretti G, et al. Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. Metab Clin Exp 1994; 43: 1470-4.
7. 7 Schmidt A, Hori O, Brett J, Yan S, Wautier J, Stern D. Cellular receptors for advanced glycation end products. Arterioscl Thromb 1994; 14: 1521-8.
8. 8 Wautier J, Wautier M, Schmidt A, Anderson G, Hori O, Zoukourian C, et al. Advanced glycation end products on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic colmplications. Proc Natl Acad Sci USA 1994; 91: 7742-6.
9. 9 Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 1989; 170: 1387-407.
10. 10 Hogan M, Cerami A, Bucala R. Advanced glycosylation end products block the antiproliferative effect of nitric oxide. J Clin Invest 1992; 90: 1110-5.
11. 11 Schmidt A, Hori O, Chen J, Li J, Crandall J, Zhang J, et al. Advanced glycation end products interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 1995; 96: 1395-403.
12. 12 Rattan V, Shen Y, Sultana C, Kumar D, Kalra VK. Diabetic RBC-induced oxidant stress leads to transendothelial migration of monocyte-like HL-60 cells. Am J Physiol 1997; 273 (Endocrinol Metab 36): E369-75.
13. 13 Hebbel RP, Boogaerts MAB, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle cell anemia. A possible determinant of disease severity. N Engl J Med 1980; 302: 992-5.
14. 14 Mohandas N, Evans E. Adherence of sickle erythrocytes to vascular endothelial cells: requirement for both cell membrane changes and plasma factors. Blood 1984; 64: 282-7.
15. 15 Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997; 99: 2561-4.
16. 16 Kaul DK, Fabry ME, Nagel RE. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiological implications. Proc Natl Acad Sci USA 1989; 86: 3356-60.
17. 17 Brittain HA, Eckman JR, Wick TM. Sickle erytrocyte adherence to large vessel and microvascular endothelium under physiologic flow is qualitatively different. J Lab Clin Med 1992; 120: 538-45.
18. 18 Vordermeier S, Singh S, Biggerstaff J, Harrison P, Grech H, Pearson TC, et al. Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumour necrosis factor (TNF). Br J Haematol 1992; 81: 591-7.
19. 19 Dhermy D, Simeon J, Wautier MP, Boivin P, Wautier JL. Role of membrane sialic acid content in the adhesivness of aged erythrocytes to human cultured endothelial cells. Biochim Biophys Acta 1987; 904: 201-6.
20. 20 Stone PCW, Stuart J, Nash GB. Effects of density and dehydratation of sickle cells on their adhesion to cultured endothelial cells. Am J Hematol 1996; 52: 135-43.
21. 21 Hebbel RP, Ney PA, Foker W. Autooxidation, dehydratation and adhesivity may be related abnormalities of sickle erythrocytes. Am J Physiol 1989; 256: C579-83.
22. 22 Kaul DK, Chen D, Zhan J. Adhesion of sickle cells to vascular endothelium is critically dependent on changes in density and shape of the cells. Blood 1994; 83: 3006-17.
23. 23 Klug PP, Kay N, Jensen WN. Endothelial cell and vascular damage in the sickle cell disorder. Blood Cells 1982; 8: 175-84.
24. 24 Natarayan M, Udden MM, McIntire LV. Adhesion of sickle red blood cells and damage to interleukin-1β stimulated endothelial cells under flow in vitro. Blood 1996; 87: 4845-52.
25. 25 Solovey A, Lin Yi, Browne P, Choong S, Wayner E, Hebbel RP. Circulating activated endothelial cells in sickle anemia. N Engl J Med 1997; 337: 1584-90.
26. 26 George F, Toulon P, Sampol J, Sultan Y. Detection of high levels of circulating endothelial cells in patients with sickle cell crisis [abstract]. Blood 1992; 80 Suppl: 12a.
27. 27 Richardson SGN, Mathews KB, Stuart J, Geddes AM, Wilcox RM. Serial changes in coagulation and viscosity during sickle-cell crisis. Br J Haematol 1979; 41: 95-103.
28. 1, and glycoprotein IV (CD36) are expressed on circulating reticulocytes in sickle cell anemia. Blood 1993; 82: 3548-55.
29. 29 Sugihara K, Sugihara T, Mohandas N, Hebbel RP. Thrombospondin mediates adherence of CD 36+ sickle reticulocytes to endothelial cells. Blood 1992; 80: 2634-42.
30. 30 Brittain HA, Eckman JR, Howard RJ, Wick TM. Thrombospondin from activated platelets promotes sickle erythrocyte adherence to human microvascular endothelium under physiologic flow: a potential rôle for platelet activation in sickle cell vaso-occlusion. Blood 1993; 81: 2137-43.
31. 31 Tandon NN, Kralisz U, Jamieson GA. Identification of GP IV (CD 36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989; 264: 7576-83.
32. 1 integrin receptors on sickle reticulocytes and fibronectin. Blood 1996; 88: 4348-58.
33. 33 Hillery CA, Du MC, Montgomery RR, Scott JP. Increased adhesion of erythrocytes to components of the extracellular matrix: isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin. Blood 1996; 87: 4879-86.
34. 34 Das SK, Nair RC. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxydation of normal sickled erythrocytes. Br J Haematol 1980; 44: 87-98.
35. 35 Hebbel RP, Moldow CF, Steinberg MH. Modulation of erythrocyte endothelial interactions and the vaso-occlusive severity of sickling disorders. Blood 1981; 58: 947-52.
36. 36 Wick TM, Moake JL, Udden MM, McIntire LV. Unusually large von Willebrand factor multimers preferentially promote young sickle and nonsickle erythrocyte adhesion to endothelial cells. Am J Hematol 1993; 42: 284-92.
37. 37 Moake JL. Haemolytic-uraemic syndrome: basic science. Lancet 1994; 343: 393-7.
38. 1-integrin expression on sickle reticulocytes: vascular cell adhesion molecule-1-dependent binding to endothelium. Blood 1993; 82: 1891-9.
39. 39 Setty BNY, Stuart M. Vascular cell adhesion molecule-1 is involved in mediating hypoxia-induced sickle red blood cell adherence to endothelium: potential role in sickle cell disease. Blood 1996; 88: 2311-20.
40. 40 Setty BNY, Dampier CD, Stuart MJ. Arachidonic acid metabolites are involved in mediating red blood cell adherence to endothelium. J Lab Clin Med 1995; 125: 608-17.
41. 41 Hebbel RP. Adhesive interactions of sickle erythrocytes with endothelium. J Clin Invest 1997; 99: 2561-4.
42. 42 Thevenin BJM, Crandall I, Ballas KS, Sherman IW, Shohet BS. Band 3 peptides block the adherence of sickle cells to endothelial cells in vitro. Blood 1997; 90: 4172-9.
43. 43 Phelan M, Perrine SP, Brauer M, Faller DV. Transcriptional regulation of vasoactive genes in human endothelial cells by sickled cell or plasma from patients in crisis. Blood 1995; 86 Suppl 1: 418a.
44. 44 Phelan M, Perrine SP, Brauer M, Faller Dv. Sickle erythrocytes, after sickling, regulate the expression of the endothelin-1 gene and protein in human endothelial cells in culture. J Clin Invest 1995; 96: 1145-51.
45. 45 Barwell JW, Ockenhouse CF, Knowles IIDM. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum infected erythrocytes to monocytes, endothelial, and C32 melanoma cells. J Immunol 1985; 135: 3494-7.
46. 46 Roberts DD, Sherwood JA, Spitalnik SL. Thrombospondin binds falciparum malaria parasitized erythrocytes and may mediate cytoadherence. Nature 1985; 318: 64-6.
47. 47 Berendt A, Simmons D, Tansey J. Intracellular adhesion molecule-1 is an endothelial receptor for Plasmodium falciparum. Nature 1989, 341: 57-9.
48. 48 Howard RJ, Gilladoga AD: Molecular studies related to the pathogenesis of cerebral malaria. Blood 1989; 74: 2603.
49. 49 Kaul DK, Liu XD, Nagel RL, Shear HL. Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria. Am J Trop Med Hyg 1998; 58: 240-7.
50. 50 Cooke B, Berendt A., Graig A, Mc Gregor J, Newbold C, Nash G. Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1,CD-36 and thrombospondin. Br J Haematol 1994; 87: 162-70.
51. 51 Mc Cormick CJ, Craig A, Roberts D, Newbold CL, Berendt AR, Intercellular addhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J Clin Invest 1997; 100: 2521-9.
52. 52 Ockenhouse CF, Tegoshi T, Maeno Y. Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for an endothelial leukocyte adhesion molecule-1 and vascular cell adhesion molecule-1. J Exp Med 1992; 176: 1183-9.
53. 53 Udomsangpetch R, Taylor BJ, Looareesuwan S, White NJ, Elliott JF, Ho M. Receptor specificity of clinical Plasmodium falciparum isolates: nonadherence to cell-bound E-selectin and vascular cell adhesion molecule-1. Blood 1996; 88: 2754-60.
54. 54 Cooke B, Rogerson S, Brown G, Coppel R. Adhesion of malaria-infected red blood cells to chondroitin sulfate A under flow conditions. Blood 1996; 88: 4040-4.
55. 55 Boffa MC, Karmochkine M. Thrombomodulin: an overview and potential implications in vascular disorders. Lupus 1998; 7: S120-5.
56. 56 Rogerson SJ, Novakovic S, Cooke BM, Brown GV. Plasmodium falciparum-erythrocytes adhere to proteoglycan thrombomodulin in static and flow-based systems. Exp Parasitol 1997; 86: 8-18.
57. 57 Treutiger CJ, Heddini A, Fernandez V, Muller WA, Wahlgren M. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nature Med 1997; 3: 1405-8.
58. 58 Schwartz RS, Olson JA, Raventos Suarez C, Yee m, Heath RH, Lubin B, et al. Altered plasma membrane phospholipid organization in Plasmodium falciparum infected human erythrocytes. Blood 1987; 69: 401-7.
59. 59 Biggs BA, Culvenor JG, NG JS, Kemp DJ, Brown GV. Plasmodium falciparum: cytoadherence of a knobless clone. Exp Parasitol 1989; 69: 189-97.
60. 60 Berendt AR, Ferguson DJP, Gardner J, Turner G, Rowe A, Mc Cormick C, et al. Molecular mechanisms of sequestration in malaria. Parasitology 1994; 108: S19-28.
61. 61 Sherman IW, Crandall I, Smith H. Membrane proteins involved in the adherence of Plasmodium falciparum-infected erythrocyte membrane. Biol Cell 1992; 74: 161-78.
62. 62 Crandall I, Collins WE, Gysin J, Sherman IW. Synthetic peptides based on motifs present in human band 3 protein inhibit cytoadherence/sequestration of Plasmodium falciparum (human malaria). Proc Natl Acad Sci USA 1993; 90: 4703-7.
63. 63 Crandall I, Land KM, Sherman IW. Plasmodium falciparum: Pfalhesin and CD36 form an adhesin/receptor pair that is responsible for the dependent portion of cytoadherence/sequestration. Exp Parasitol 1994; 78: 203-9.
64. 64 Leech JH, Barnwell JW, Miller LH, Howard RJ. Identification of a strain-specific malarial antigen on the surface of Plasmodium falciparum-infected erythrocytes. J Exp Med 1984; 159: 1567-75.
65. 65 Baruch DI, Paloske BL, Singh Hb, Bi X, Ma XC, Feldman M. Cloning the Plasmodium falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes. Cell 1995; 82: 77-87.
66. 66 Biggs BA, Gooze L, Wycherley K, Wollish W, Southwell B, Leech JH, et al. Antigenic variation in Plasmodium falciparum. Proc Natl Acad Sci USA 1991; 88: 9171-4.
67. 67 Baruch DI, Gormley JA, Ma C, Howard RJ, Paloske BL. Plasmodium falciparum erythrocyte protein 1 is a parasitized erythrocyte receptor for adherence to CD36, thrombospondin, and intercellular adhesion molecule-1. Proc Natl Acad Sci USA 1996; 93: 3497-502.
68. 68 Gardner JR, Pinches RA, Roberts DJ, Newbold CI. Variant antigens and endothelial receptor adhesion in Plasmodium falciparum. Proc Natl Acad Sci USA 1996; 93: 3503-8.
69. 69 Biggs BA, Anders RF, Dillon HE, Davern KM, Martin M, Petersen C, et al. Adherence of infected erythrocytes to venular endothelium selects for antigenic variants of Plasmodium falciparum. J Immunol 1992; 149: 2047-54.
70. 70 Ockenhouse CF, Klotz FW, Tandon NN, Jamieson GA. Sequestrin, a CD36 recognition protein on Plasmodium falciparum malaria-infected erythrocytes identified by anti-idiotype antibodies. Proc Natl Acad Sci USA 1991; 88: 3175-9.
71. 71 Paloske BL, Howard RJ. Malaria, the red cell, and the endothelium. Annu Rev Med 1994; 45: 283-95.